| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |